Chrysus Translation
Services
“Providing solutions to your medical and clinical trial
document translation needs”
OUR SERVICES
Translation
Proofreading
Translation Project Management
Editing
Back Translation
About Us
Who we are and what we do?
Chrysus Translation Services is a highly competitive document translation firm, providing medical and clinical-related document translations to different pharmaceutical, Contract Research Organizations, and healthcare companies. We are a team of medical professionals united to create innovative solutions to the ever-changing demands of the industry. We specialize in medical and clinical trial document translations to provide and deliver the highest quality of translation to our clients
Why Choose Us
Solutions To Meet Your Global Business Ambitions
Your company’s growth is now beyond international boundaries, and it cannot continue without appropriate multilingual content solutions that remove the barriers standing in the way of your success on a worldwide scale.
With our excellent language solutions, we at Chrysus help you complete the puzzle and expand your business beyond your limited local market.
Features
English ↔ Tagalog
English ↔ Cebuano(Cebu and Davao)
English ↔ Hiligaynon (Ilonggo)
English ↔ Iloko (Ilocano)
We also offer translation services in different languages like Arabic, Vietnamese, Thai, Bengali, Spanish, Latin America, Danish, and Finnish.
14 Dayot Street, Poblacion, Dingle, Iloilo, Philippines 5035
Call: (033) 321-7312
Experts In our field
Meet Our Team
ESRAA MASSOUD
Project Manager
KIM LAMSON
Founder / Business Development Head .
KATRINA JOY ALIGAM, MD
Medical Director
Ready to join our pool of Translators?
If you are a linguist with a Translation degree or 3-5 years of experience then we would like to hear from you to join our Freelance Family.
Chrysus Translation Services is a highly competitive document translation firm, providing medical and clinical related document translations to different pharmaceutical, Contract Research Organizations and healthcare companies.